Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

Abstract

Purpose: Overweight/obese (OW/OB) patients with metastatic melanoma unexpectedly have improved outcomes with immune checkpoint inhibitors (ICIs) and BRAF-targeted therapies. The mechanism(s) underlying this association remain unclear, thus we assessed the integrated molecular, metabolic, and immune profile of tumors, as well as gut microbiome features, for associations with patient BMI. Experimental Design: Associations between BMI [normal (NL < 25) or OW/OB (BMI ≥ 25] and tumor or microbiome characteristics were examined in specimens from 782 metastatic melanoma patients across 7 cohorts. DNA associations were evaluated in the TCGA cohort. RNASeq from 4 cohorts (n=357) was batch corrected and gene set enrichment analysis (GSEA) by BMI category was performed. Metabolic profiling was conducted in a subset of patients (x=36) by LC/MS, and in flow-sorted melanoma tumor cells (x=37) and patient-derived melanoma cell lines (x=17) using the Seahorse XF assay. Gut microbiome features were examined in an independent cohort (n=371). Results: DNA mutations and copy number variations were not associated with BMI. GSEA demonstrated that tumors from OW/OB patients were metabolically quiescent, with downregulation of oxidative phosphorylation and multiple other metabolic pathways. Direct metabolite analysis and functional metabolic profiling confirmed decreased central carbon metabolism in OW/OB metastatic melanoma tumors and patient-derived cell lines. The overall structure, diversity, and taxonomy of the fecal microbiome did not differ by BMI. Conclusions: These findings suggest that the host metabolic phenotype influences melanoma metabolism and provide insight into the improved outcomes observed in OW/OB patients with metastatic melanoma treated with ICIs and targeted therapies.

Obesity-related T cell dysfunction impairs immunosurveillance and increases cancer risk

“…The mechanisms underlying this counterintuitive phenomenon have not been fully explained, but recent clinical findings indicate that differences in tumor mutational burden (TMB) play a role 43 . Seemingly conflicting data from another study suggested that human melanoma TMB is similar between lean and obese patients 44 . However, that analysis combined over-weight and obese cohorts (BMI > 25), hindering the ability to assess how TMB is influenced specifically in patients with obesity.…”

Non-alcoholic fatty liver disease promotes liver metastasis of colorectal cancer via fatty acid synthase dependent EGFR palmitoylation

“…Recent reports have revealed that systemic metabolism significantly influences cancer cell metabolism [ 13 , 54 ]. As for primary tumors, the tumor metabolic microenvironment is determined by the cellular metabolism of tumor cells and other TME components, metabolic interactions between tumor and non-tumor cells, and their communication with the systemic metabolism of the whole body [ 55 ].…”

Possible Mechanisms of Dark Tea in Cancer Prevention and Management: A Comprehensive Review

“…Studies have indicated that excessive obesity can increase the risk of colon cancer and breast cancer, and obesity can promote tumorigenesis by stimulating inflammatory responses in the body [ 103 ]. Dark tea has been reported to lower lipids, which provides another perspective for the prevention and treatment of cancer [ 104 , 105 ].…”